Pharmena S.A. (WSE:PHR)
Poland
· Delayed Price · Currency is PLN 3.080
+0.100 (3.36%)
Dec 5, 2025, 4:26 PM CET
Pharmena Revenue
Pharmena had revenue of 407.00K PLN in the quarter ending September 30, 2025, with 1,750.00% growth. This brings the company's revenue in the last twelve months to 1.27M, up 313.64% year-over-year. In the year 2024, Pharmena had annual revenue of 268.00K, down -10.37%.
Revenue (ttm)
1.27M
Revenue Growth
+313.64%
P/S Ratio
26.93
Revenue / Employee
182.00K
Employees
7
Market Cap
34.30M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 268.00K | -31.00K | -10.37% |
| Dec 31, 2023 | 299.00K | - | - |
| Dec 31, 2022 | 299.00K | -14.91M | -98.03% |
| Dec 31, 2021 | 15.21M | 5.28M | 53.16% |
| Dec 31, 2020 | 9.93M | -1.17M | -10.51% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Diagnostyka | 2.30B |
| NEUCA | 13.34B |
| Synektik Spólka Akcyjna | 623.20M |
| Voxel | 568.83M |
| Celon Pharma | 225.60M |
| Selvita | 373.90M |
| Ryvu Therapeutics | 90.41M |
| Centrum Medyczne ENEL-MED | 820.59M |